These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 27437873

  • 1. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.
    Ríos-Tamayo R, Lupiañez CB, Campa D, Hielscher T, Weinhold N, Martínez-López J, Jerez A, Landi S, Jamroziak K, Dumontet C, Wątek M, Lesueur F, Reis RM, Marques H, Jurczyszyn A, Vogel U, Buda G, García-Sanz R, Orciuolo E, Petrini M, Vangsted AJ, Gemignani F, Försti A, Goldschmidt H, Hemminki K, Canzian F, Jurado M, Sainz J.
    Oncotarget; 2016 Sep 13; 7(37):59029-59048. PubMed ID: 27437873
    [Abstract] [Full Text] [Related]

  • 2. SLC30A8 gene polymorphism rs13266634 associated with increased risk for developing type 2 diabetes mellitus in Jordanian population.
    Mashal S, Khanfar M, Al-Khalayfa S, Srour L, Mustafa L, Hakooz NM, Zayed AA, Khader YS, Azab B.
    Gene; 2021 Feb 05; 768():145279. PubMed ID: 33161057
    [Abstract] [Full Text] [Related]

  • 3. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.
    Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J.
    Endocr Relat Cancer; 2015 Aug 05; 22(4):545-59. PubMed ID: 26099684
    [Abstract] [Full Text] [Related]

  • 4. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
    Macauda A, Clay-Gilmour A, Hielscher T, Hildebrandt MAT, Kruszewski M, Orlowski RZ, Kumar SK, Ziv E, Orciuolo E, Brown EE, Försti A, Waller RG, Machiela MJ, Chanock SJ, Camp NJ, Rymko M, Raźny M, Cozen W, Várkonyi J, Piredda C, Pelosini M, Belachew AA, Subocz E, Hemminki K, Rybicka-Ramos M, Giles GG, Milne RL, Hofmann JN, Zaucha JM, Vangsted AJ, Goldschmidt H, Rajkumar SV, Tomczak W, Sainz J, Butrym A, Watek M, Iskierka-Jazdzewska E, Buda G, Robinson DP, Jurczyszyn A, Dudziński M, Martinez-Lopez J, Sinnwell JP, Slager SL, Jamroziak K, Reis RMV, Weinhold N, Bhatti P, Carvajal-Carmona LG, Zawirska D, Norman AD, Mazur G, Berndt SI, Campa D, Vachon CM, Canzian F.
    Cancer Epidemiol Biomarkers Prev; 2022 Sep 02; 31(9):1863-1866. PubMed ID: 35700034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of rs11558471 in SLC30A8 Gene with Interleukin 17 Serum Levels and Insulin Resistance in Iranian Patients with Type 2 Diabetes.
    Ahmadi M, Mahrooz A, Abediankenari S, Hayati Roodbari N.
    Iran J Immunol; 2020 Sep 02; 17(3):215-225. PubMed ID: 32996898
    [Abstract] [Full Text] [Related]

  • 8. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
    Macauda A, Piredda C, Clay-Gilmour AI, Sainz J, Buda G, Markiewicz M, Barington T, Ziv E, Hildebrandt MAT, Belachew AA, Varkonyi J, Prejzner W, Druzd-Sitek A, Spinelli J, Andersen NF, Hofmann JN, Dudziński M, Martinez-Lopez J, Iskierka-Jazdzewska E, Milne RL, Mazur G, Giles GG, Ebbesen LH, Rymko M, Jamroziak K, Subocz E, Reis RM, Garcia-Sanz R, Suska A, Haastrup EK, Zawirska D, Grzasko N, Vangsted AJ, Dumontet C, Kruszewski M, Dutka M, Camp NJ, Waller RG, Tomczak W, Pelosini M, Raźny M, Marques H, Abildgaard N, Wątek M, Jurczyszyn A, Brown EE, Berndt S, Butrym A, Vachon CM, Norman AD, Slager SL, Gemignani F, Canzian F, Campa D.
    Int J Cancer; 2021 Jul 15; 149(2):327-336. PubMed ID: 33675538
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
    Kasamatsu T, Saitoh T, Ino R, Gotoh N, Mitsui T, Shimizu H, Matsumoto M, Sawamura M, Yokohama A, Handa H, Tsukamoto N, Murakami H.
    Hematol Oncol; 2017 Dec 15; 35(4):711-718. PubMed ID: 27405747
    [Abstract] [Full Text] [Related]

  • 10. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
    Machiela MJ, Lindström S, Allen NE, Haiman CA, Albanes D, Barricarte A, Berndt SI, Bueno-de-Mesquita HB, Chanock S, Gaziano JM, Gapstur SM, Giovannucci E, Henderson BE, Jacobs EJ, Kolonel LN, Krogh V, Ma J, Stampfer MJ, Stevens VL, Stram DO, Tjønneland A, Travis R, Willett WC, Hunter DJ, Le Marchand L, Kraft P.
    Am J Epidemiol; 2012 Dec 15; 176(12):1121-9. PubMed ID: 23193118
    [Abstract] [Full Text] [Related]

  • 11. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
    Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, Patel AV, Berndt SI, Albanes D, Hayes RB.
    Prostate; 2010 May 01; 70(6):601-7. PubMed ID: 19998368
    [Abstract] [Full Text] [Related]

  • 12. Exploring the Association Between Demographics, SLC30A8 Genotype, and Human Islet Content of Zinc, Cadmium, Copper, Iron, Manganese and Nickel.
    Wong WP, Allen NB, Meyers MS, Link EO, Zhang X, MacRenaris KW, El Muayed M.
    Sci Rep; 2017 Mar 28; 7(1):473. PubMed ID: 28352089
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
    Elliott KS, Zeggini E, McCarthy MI, Gudmundsson J, Sulem P, Stacey SN, Thorlacius S, Amundadottir L, Grönberg H, Xu J, Gaborieau V, Eeles RA, Neal DE, Donovan JL, Hamdy FC, Muir K, Hwang SJ, Spitz MR, Zanke B, Carvajal-Carmona L, Brown KM, Australian Melanoma Family Study Investigators, Hayward NK, Macgregor S, Tomlinson IP, Lemire M, Amos CI, Murabito JM, Isaacs WB, Easton DF, Brennan P, PanScan Consortium, Barkardottir RB, Gudbjartsson DF, Rafnar T, Hunter DJ, Chanock SJ, Stefansson K, Ioannidis JP.
    PLoS One; 2010 May 28; 5(5):e10858. PubMed ID: 20526366
    [Abstract] [Full Text] [Related]

  • 14. Computational and functional analyses of T2D GWAS SNPs for transcription factor binding.
    Cheng M, Huang X, Zhang M, Huang Q.
    Biochem Biophys Res Commun; 2020 Mar 12; 523(3):658-665. PubMed ID: 31948755
    [Abstract] [Full Text] [Related]

  • 15. Computational analyses of type 2 diabetes-associated loci identified by genome-wide association studies.
    Cheng M, Liu X, Yang M, Han L, Xu A, Huang Q.
    J Diabetes; 2017 Apr 12; 9(4):362-377. PubMed ID: 27121852
    [Abstract] [Full Text] [Related]

  • 16. Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
    Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudziński M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Wątek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C.
    Nat Commun; 2015 Jul 22; 6():7539. PubMed ID: 26198393
    [Abstract] [Full Text] [Related]

  • 17. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
    Martino A, Campa D, Jurczyszyn A, Martínez-López J, Moreno MJ, Varkonyi J, Dumontet C, García-Sanz R, Gemignani F, Jamroziak K, Stępieł A, Jacobsen SE, Andersen V, Jurado M, Landi S, Rossi AM, Lesueur F, Marques H, Dudziński M, Wątek M, Moreno V, Orciuolo E, Petrini M, Reis RM, Ríos R, Sainz J, Vogel U, Buda G, Vangsted AJ, Canzian F.
    Cancer Epidemiol Biomarkers Prev; 2014 Apr 22; 23(4):670-4. PubMed ID: 24521996
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
    Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, Vieira Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Bugert P, Moreno V, Szemraj J, Orciuolo E, Gemignani F, Rossi AM, Dumontet C, Petrini M, Goldschmidt H, Landi S, Canzian F.
    Br J Haematol; 2012 May 22; 157(3):331-8. PubMed ID: 22590720
    [Abstract] [Full Text] [Related]

  • 19. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
    Melaiu O, Macauda A, Sainz J, Calvetti D, Facioni MS, Maccari G, Ter Horst R, Netea MG, Li Y, Grząśko N, Moreno V, Jurczyszyn A, Jerez A, Watek M, Varkonyi J, Garcia-Sanz R, Kruszewski M, Dudziński M, Kadar K, Jacobsen SEH, Mazur G, Andersen V, Rybicka M, Zawirska D, Raźny M, Zaucha JM, Ostrovsky O, Iskierka-Jazdzewska E, Reis RM, Stępień A, Beider K, Nagler A, Druzd-Sitek A, Marques H, Martìnez-Lopez J, Lesueur F, Avet-Loiseau H, Vangsted AJ, Krawczyk-Kulis M, Butrym A, Jamroziak K, Dumontet C, Vogel U, Rymko M, Pelosini M, Subocz E, Szombath G, Sarasquete ME, Silvestri R, Morani F, Landi S, Campa D, Canzian F, Gemignani F.
    Int J Cancer; 2021 Apr 15; 148(8):1887-1894. PubMed ID: 33152124
    [Abstract] [Full Text] [Related]

  • 20. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk.
    Sainz J, Rudolph A, Hoffmeister M, Frank B, Brenner H, Chang-Claude J, Hemminki K, Försti A.
    J Clin Endocrinol Metab; 2012 May 15; 97(5):E845-51. PubMed ID: 22419714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.